Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
129,668,560
-
Number of holders
-
261
-
Total 13F shares, excl. options
-
117,354,505
-
Shares change
-
+1,202,087
-
Total reported value, excl. options
-
$1,887,976,537
-
Value change
-
+$17,892,372
-
Put/Call ratio
-
32%
-
Number of buys
-
116
-
Number of sells
-
-115
-
Price
-
$16.07
Significant Holders of NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) as of Q2 2023
298 filings reported holding NEO - NEOGENOMICS INC - Common Stock, par value $0.001 per share as of Q2 2023.
NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO) has 261 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 117,354,505 shares
of 129,668,560 outstanding shares and own 91% of the company stock.
Largest 10 shareholders include BlackRock Inc. (20,776,212 shares), VANGUARD GROUP INC (14,640,814 shares), JANUS HENDERSON GROUP PLC (7,589,487 shares), BROWN ADVISORY INC (6,594,485 shares), T. Rowe Price Investment Management, Inc. (5,059,586 shares), STATE STREET CORP (4,926,392 shares), Greenhouse Funds LLLP (3,294,817 shares), DIMENSIONAL FUND ADVISORS LP (2,980,374 shares), First Light Asset Management, LLC (2,692,057 shares), and GEODE CAPITAL MANAGEMENT, LLC (2,617,439 shares).
This table shows the top 261 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.